Retinal neovacularization is seen in A/E
## Core Concept
Retinal neovascularization refers to the formation of new, fragile blood vessels in the retina, often in response to ischemia or inflammation. This process can lead to vision-threatening complications, such as vitreous hemorrhage and retinal detachment. It is a hallmark of several retinal diseases.
## Why the Correct Answer is Right
The correct answer, **Diabetic Retinopathy**, is a condition where retinal neovascularization is commonly observed. In diabetic retinopathy, especially the proliferative form, retinal ischemia leads to the production of vascular endothelial growth factors (VEGF), promoting the growth of new, fragile vessels. This is a key feature that distinguishes proliferative diabetic retinopathy from non-proliferative diabetic retinopathy.
## Why Each Wrong Option is Incorrect
- **Option A: Retinopathy of Prematurity** - This condition primarily affects premature infants and involves abnormal vascular development in the retina. While it does involve vascular changes, the primary issue is not typically described as neovascularization in the same sense as diabetic retinopathy but rather as a failure of normal vascular development.
- **Option B: Retinal Vein Occlusion** - This condition can lead to retinal neovascularization, particularly if it results in retinal ischemia. The ischemia acts as a stimulus for neovascularization.
- **Option D: Age-related Macular Degeneration (AMD)** - While AMD primarily affects the macula and can involve choroidal neovascularization (growth of new vessels from the choroid), it is less commonly associated with retinal neovascularization.
## Clinical Pearl / High-Yield Fact
A key clinical pearl is that retinal neovascularization is a critical factor in the progression and treatment of proliferative diabetic retinopathy. Treatments often focus on reducing ischemia and/or directly addressing neovascularization, such as with anti-VEGF injections or laser photocoagulation.
## Correct Answer Line
**Correct Answer: C. Diabetic Retinopathy**